--scientific study to evaluate the in vitro effects on MncI2 and AI2(SO4)3 on myeloid, erythroid, and mesenchymal progenitors and neurosphere proliferation and differentiation.

The contract involves the US Army Research, Development and Engineering Command (RDECOM) Natick Contracting Division acting on behalf of the Naval Health Research Center's Environmental Health Effects Laboratory. It targets a sole source purchase order with StemCell Technologies to undertake a specialized scientific study. The study aims to assess the in vitro effects of chemical compounds MncI2 and AI2(SO4)3 on different cell progenitors—myeloid, erythroid, and mesenchymal—as well as on the proliferation and differentiation of neurospheres. The research will be led by a principal investigator recognized as a leader in this scientific field, who will provide the necessary expertise for the project. This acquisition is under solicitation number W911QY08TSCTI and pertains to the North American Industry Classification System code 541380, which relates to scientific research and development services. The contract is managed by the Department of Defense office located in Natick, Massachusetts. Interested parties or those with questions about this acquisition have been directed to contact Mr. Thomas Bouchard. The study is significant for advancing understanding of these compounds' biological effects on various progenitor cells, which may have implications for health and environmental research.